Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia

NCT04990830 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Acute Respiratory Distress Syndrome
Hypoxemia

Interventions

DRUG: Inhaled Low molecular weight heparin
DRUG: Standard Treatment

Sponsor

Istanbul University